The effect of the selective Cytopheretic device on acute kidney injury outcomes in the intensive care unit: A multicenter pilot study

Seminars in Dialysis

Volumn 26, Issue 5, 2013, Pages 616-623

  Tumlin, James A ^a   Chawla, Lakhmir ^b   Tolwani, Ashita J ^c   Mehta, Ravindra ^d   Dillon, John ^e   Finkel, Kevin W ^f   Dasilva, J Ricardo ^g   Astor, Brad C ^h   Yevzlin, Alexander S ^h   Humes, H David ⁱ  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^e MAYO CLINIC   (United States)

^f UNIVERSITY OF TEXAS   (United States)

^g CytoPherx Inc   (United States)

^h UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

ⁱ UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE KIDNEY FAILURE; ADOLESCENT; ADULT; AGED; ARTICLE; FEMALE; HUMAN; INTENSIVE CARE UNIT; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; PROSPECTIVE STUDY; RENAL REPLACEMENT THERAPY; SINGLE BLIND PROCEDURE; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES; VERY ELDERLY; YOUNG ADULT;

ACUTE KIDNEY INJURY; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL REPLACEMENT THERAPY; SINGLE-BLIND METHOD; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

EID: 84884704466     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/sdi.12032     Document Type: Article

References (24)

1. Waikar SS, Curhan GC, Wald R, McCarthy EP, Chertow GM: Declining mortality in patients with acute renal failure, 1988 to 2002. J Am Soc Nephrol17:1143-1150, 2006
2. Xue JL, Daniels F, Star RA, Kimmel PL, Eggers PW, Molitoris BA, Himmelfarb J, Collins AJ: Incidence and mortality of acute renal failure in Medicare beneficiaries, 1991-2002. J Am Soc Nephrol17:1135-1142, 2006
3. Yevzlin AS, Humes HD: Cell therapy, advanced materials, and new approaches to acute kidney injury. Hosp Pract37:1, 2010
4. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C; Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators: For the Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) investigators: acute renal failure in critically ill patients: a multinational, multicenter study. JAMA294:813-818, 2005
5. Mehta RL, Pascual MT, Soroko S, Savage BR, Himmelfarb J, Ikizler TA, Paganini EP, Chertow GM: Program to improve care in acute renal disease. Spectrum of acute renal failure in the intensive care unit: the PICARD experience. Kidney Int66:1613-1621, 2004
6. RENAL Replacement Therapy Study Investigators, Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Lo S, McArthur C, McGuinness S, Myburgh J, Norton R, Scheinkestel C, Su S: Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med361(17):1627-1638, 2009
7. Breen D, Bihari D: Acute renal failure as a part of multiple organ failure: the slippery slope of critical illness. Kidney Int Suppl66:S25-S33, 1998
8. Humes HD: Bioartificial kidney for full renal replacement therapy. Semin Nephrol20:71-82, 2000
9. Humes HD, MacKay SM, Funke AJ, Buffington DA: The bioartificial renal tubule assist device to enhance CRRT in acute renal failure. Am J Kidney Dis30:S28-S31, 1997
10. Lu CY, Hartono J, Senitko M, Chen J: The inflammatory response to ischemic acute kidney injury: a result of the 'right stuff' in the 'wrong place'?Curr Opin Nephrol Hypertens16:83-89, 2007
11. Okusa MD: The inflammatory cascade in acute ischemic renal failure. Nephron90:133-138, 2002
12. Ding F, Song JH, Jung JY, Lou L, Wang M, Charles L, Westover A, Smith PL, Pino CJ, Buffington DA, Humes HD: A biomimetic membrane device that modulates the excessive inflammatory response to sepsis. PLoS ONE6(4):e18584, 2011
13. Ding F, Yevzlin AS, Xu ZY, Zhou Y, Xie QH, Liu JF, Zheng Y, DaSilva JR, Humes HD: The effects of a novel therapeutic device on acute kidney injury outcomes in the intensive care unit: a pilot study. ASAIO J57(5):426-432, 2011
14. Sutton TA, Fisher CJ, Molitoris BA: Endothelial injury and dysfunction during the extension phase of acute renal failure. Kidney Int62:1539-1549, 2002
15. Sutton TA, Mang HE, Campos SB, Sandoval RM, Yoder MC, Molitoris BA: Injury of the renal microvascular endothelium alters barrier function after ischemia. Am J Physiol Renal Physiol285:F191-F198, 2003
16. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C: Acute renal failure in critically ill patients: a multinational, multicenter study. Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) investigators. JAMA294(7):813-818, 2005
17. Lins RL, Elseviers MM, Van der Niepen P, Hoste E, Malbrain ML, Damas P, Devriendt J: Intermittent versus continuous renal replacement therapy for acute kidney injury patients admitted to the intensive care unit: results of a randomized clinical trial. Nephrol Dial Transplant24:512-518, 2009
18. Vesconi S, Cruz DN, Fumagalli R, Kindgen-Milles D, Monti G, Marinho A, Mariano F, Formica M, Marchesi M, René R, Livigni S, Ronco C: Delivered dose of renal replacement therapy and mortality in critically ill patients with acute kidney injury. Crit Care13:R57, 2009
19. Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, La Greca G: Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet356:26-30, 2000
20. Palevsky PM, Zhang JH, O'Connor TZ, Chertow GM, Crowley ST, Choudhury D, Finkel K, Kellum JA, Paganini E, Schein RM, Smith MW, Swanson KM, Thompson BT, Vijayan A, Watnick S, Star RA, Peduzzi P: Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med359(1):7-20, 2008. Epub 2008 May VA/NIH Acute Renal Failure Trial Network
21. Vinsonneau C, Camus C, Combes A, Costa de Beauregard MA, Klouche K, Boulain T, Pallot JL, Chiche JD, Taupin P, Landais P, Dhainaut JF: Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial. Lancet368:379-385, 2006
22. Mehta RL, McDonald BR, Gabbai FB, Pahl M, Pascual MT, Farkas A, Kaplan RM; Collaborative Group for Treatment of ARF in the ICU: A randomized clinical trial of continuous vs intermittent dialysis for acute renal failure. Kidney Int60:1154-1163, 2001
23. Sandy D, Moreno L, Lee J, Paganini EP: A randomized stratified, dose equivalent comparison of continuous veno-venous hemodialysis (CVVHD) vs intermittent hemodialysis (IHD) support in ICU acute renal failure patients (ARF). J Am Soc Nephrol9:225A, 1998 (abstract)
24. Jager KJ, Stel VS, Wanner C, Zoccali C, Dekker FW: The valuable contribution of observational studies to nephrology. Kidney Int72:671-675, 2007